The fundamental problem Theranos failed at overcoming was that you can’t accurately measure many things using small volumes of blood. All of the fraud was aimed at covering that up. (Glucose concentration is one of the few tests that does work with low volumes.) The CoV test we’re talking about has the same fundamental issue — you can’t have an accurate test for an antigen using a small amount of blood.

It’s less of a biological problem and more of a statistical sampling problem. The chances of there being a CoV antigen in the small drop of blood that you’d measure with a glucose monitor is very small. Sure, it might work, and the theory behind the device is sound. However, if you had a negative test, you’d never know if it was because you didn’t have CoV or if you just didn’t have any in that small blood sample.

I’d be happy to be wrong about this. A quick blood check as opposed to a 15min (the Abbott test) or 24hr (to 1 week with this backlog) wait would be amazing. But the amount of validation you’d need to demonstrate effectiveness would be equally amazing.

It doesn’t appear that’s the case

https://www.amazon.com/GenUltimate-Blood-Glucose-Strips-Mete...

The point is that it’s biologically impossible to test for some things with a finger prick. Theranos was like an electronics company claiming to have “solved” the uncertainty principle. In all these tests people are proposing, you still have to abide by the biological requirements.